ACARIZAX® approved in Canada for treatment of young children
ALK (ALKB:DC / OMX: ALK B) today announced that Health Canada has approved ALK’s ACARIZAX® tablet for use in children,...
ALK (ALKB:DC / OMX: ALK B) today announced that Health Canada has approved ALK’s ACARIZAX® tablet for use in children,...
Philadelphia, Pennsylvania--(Newsfile Corp. - March 6, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) (the "Company") today announced the pricing of...
UTRECHT, The Netherlands, March 6, 2025 /PRNewswire/ -- Vitestro, a pioneer in medical robotics, proudly reveals the name of its...
NEW YORK, March 6, 2025 /PRNewswire/ -- ProofPilot, the leading Clinical Experience Platform (CXP), today announced they will host a panel...
BOSTON, March 6, 2025 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials, and Tiefenbacher Group, a leading...
TORONTO and DALLAS, March 6, 2025 /PRNewswire/ - In advance of International Women's Day, Perimeter Medical Imaging AI, Inc. (TSXV: PINK)...
COLUMBUS, Ohio, March 6, 2025 /PRNewswire/ -- Today, clinical trials dramatically underrepresent patients who live in rural areas of the...
Two Presentations Highlight Data Demonstrating Hypericin Photodynamic Therapy Potential with a Preliminary Comparison to Current Therapy PRINCETON, N.J., March 6,...
Los Angeles, California--(Newsfile Corp. - March 6, 2025) - The St. Baldrick's Foundation, the largest charity funder of childhood cancer...
JUPITER, Fla., March 06, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI),...
March 6, 2025 Biodexa Announces Appointment of Precision for Medicine LLC as CRO for European Component of Phase 3 Study...
BASKING RIDGE, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage...
The Interim Analysis Showed Complete Clinical Clearance of More than Sixty (60%) PercentPhiladelphia, Pennsylvania--(Newsfile Corp. - March 6, 2025) -...
A growing body of clinical evidence supports the use of Firefly's FDA-Cleared BNA(TM) platform to study ACP-01 as a treatment...
Tampa General Hospital Cancer Institute hosted a day of keynotes, presentations and discussions at TGH Brooksville to address the challenges...
SEATTLE, March 5, 2025 /PRNewswire/ -- Magnolia Medical Technologies, Inc., the pioneer in Initial Specimen Diversion Device® (ISDD®) technology, today...
Research validates the efficacy and accuracy of its digital solutions designed to detect early indicators of cognitive impairment BOSTON, March...
NEW YORK, March 5, 2025 /PRNewswire/ -- According to a comprehensive report from The Insight Partners, "Health Economics and Outcome...
From many clicks to one query, drug supply managers can more quickly access, analyze, and visualize the trial supply data...
JERUSALEM and NEW YORK, March 5, 2025 /PRNewswire/ -- Arieli Group and the Jerusalem's Shaare Zedek Medical Center (SZMC) announce...